InsiderClue
Stocks · Health care · Pharmaceutical Preparations

KALA BIO, Inc.

KALA Clue Score18
United States Fiscal year ends December CIK 0001479419
$0.29 -0.88% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.29 −87.27% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 20 Jul 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−32.7Net income−33.2Fiscal year 2017Revenue0.0Operating income−39.9Net income−42.2Fiscal year 2018Operating income−64.7Net income−66.7Fiscal year 2019Revenue6.1Operating income−88.2Net income−94.3Fiscal year 2020Revenue6.4 +4.7%Operating income−96.2Net income−104.3EPS, diluted−1.99Fiscal year 2021Revenue11.2 +76.7%Operating income−130.2Net income−142.6EPS, diluted−108.32Fiscal year 2022Revenue3.9 −65.4%Operating income−81.7Net income−44.8EPS, diluted−29.48Fiscal year 2023Revenue0.0 −100.0%Operating income−39.7Net income−42.2EPS, diluted−17.35Fiscal year 2024Revenue0.0Operating income−41.0Net income−38.5EPS, diluted−10.15Fiscal year 2025Revenue0.0Operating income−39.2Net income−27.0EPS, diluted−3.31
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 n/a 6.1 6.4 11.2 3.9 0.0 0.0 0.0
Growth +4.7% +76.7% −65.4% −100.0%
Operating income −32.7 −39.9 −64.7 −88.2 −96.2 −130.2 −81.7 −39.7 −41.0 −39.2
Net income −33.2 −42.2 −66.7 −94.3 −104.3 −142.6 −44.8 −42.2 −38.5 −27.0
Growth
EPS, diluted n/a n/a n/a n/a −1.99 −108.32 −29.48 −17.35 −10.15 −3.31

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Operating margin−1,452.5%Net margin−1,553.3%Free cash flow margin−1,548.5%Fiscal year 2020Operating margin−1,512.6%Net margin−1,639.8%Fiscal year 2021Operating margin−1,158.8%Net margin−1,268.7%Fiscal year 2022Operating margin−2,099.3%Net margin−1,151.6%Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a −1,452.5% −1,512.6% −1,158.8% −2,099.3% n/a n/a n/a
Net margin n/a n/a n/a −1,553.3% −1,639.8% −1,268.7% −1,151.6% n/a n/a n/a
Free cash flow margin n/a n/a n/a −1,548.5% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−27.3Capital expenditure−0.2Free cash flow−27.5Fiscal year 2017Operating cash flow−34.1Capital expenditure−0.5Free cash flow−34.6Fiscal year 2018Operating cash flow−54.1Capital expenditure−1.6Free cash flow−55.7Fiscal year 2019Operating cash flow−92.7Capital expenditure−1.3Free cash flow−94.1Fiscal year 2020Operating cash flow−90.7Fiscal year 2021Operating cash flow−108.2Fiscal year 2022Operating cash flow−78.9Fiscal year 2023Operating cash flow−27.9Fiscal year 2024Operating cash flow−29.4Fiscal year 2025Operating cash flow−32.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −27.3 −34.1 −54.1 −92.7 −90.7 −108.2 −78.9 −27.9 −29.4 −32.0
Capital expenditure −0.2 −0.5 −1.6 −1.3 n/a n/a n/a n/a n/a n/a
Free cash flow −27.5 −34.6 −55.7 −94.1 n/a n/a n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash45.5Total debt9.7Net cash (debt)35.8Shareholders’ equity−87.8Fiscal year 2017Cash114.7Total debt18.7Net cash (debt)96.0Shareholders’ equity89.7Debt to equity0.21Fiscal year 2018Cash183.1Total debt70.2Net cash (debt)112.9Shareholders’ equity105.0Debt to equity0.67Fiscal year 2019Cash85.4Total debt71.2Net cash (debt)14.3Shareholders’ equity29.7Debt to equity2.40Fiscal year 2020Cash77.3Total debt72.2Net cash (debt)5.0Shareholders’ equity100.0Debt to equity0.72Fiscal year 2021Cash92.1Total debt78.9Net cash (debt)13.2Shareholders’ equity16.8Debt to equity4.70Fiscal year 2022Cash70.5Total debt42.9Net cash (debt)27.6Shareholders’ equity19.0Debt to equity2.26Fiscal year 2023Cash50.9Total debt34.2Net cash (debt)16.7Shareholders’ equity7.5Debt to equity4.56Fiscal year 2024Cash51.2Total debt30.4Net cash (debt)20.7Shareholders’ equity12.3Debt to equity2.47Fiscal year 2025Cash7.6Shareholders’ equity7.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 45.5 114.7 183.1 85.4 77.3 92.1 70.5 50.9 51.2 7.6
Total debt 9.7 18.7 70.2 71.2 72.2 78.9 42.9 34.2 30.4 n/a
Net cash (debt) 35.8 96.0 112.9 14.3 5.0 13.2 27.6 16.7 20.7 n/a
Shareholders’ equity −87.8 89.7 105.0 29.7 100.0 16.8 19.0 7.5 12.3 7.0
Debt to equity n/a 0.21 0.67 2.40 0.72 4.70 2.26 4.56 2.47 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−27.3 −34.1 −54.1 −92.7 −90.7 −108.2 −78.9 −27.9 −29.4 −32.0
Growth
n/a n/a n/a 0.8 0.9 1.0 0.5 0.3 0.3 0.3
Investment
−0.2 −0.5 −1.6 −1.3 n/a n/a n/a n/a n/a n/a
calc −27.5 −34.6 −55.7 −94.1 n/a n/a n/a n/a n/a n/a
Growth
−0.2 −0.5 −1.6 −1.3 −78.2 70.8 62.7 −0.4 −0.2 −0.0
Financing
67.2 103.7 124.1 9.0 160.6 42.6 −7.9 8.5 29.9 −11.6

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.